Literature DB >> 8478999

Gastrointestinal distribution of albendazole metabolites following netobimin administration to cattle: relationship with plasma disposition kinetics.

C E Lanusse1, L H Gascon, R K Prichard.   

Abstract

The gastrointestinal (GI) distribution and plasma disposition kinetics of albendazole (ABZ) metabolites after oral administration of netobimin (NTB) to cattle were studied. Eight Holstein steers (150-180 kg) were surgically fitted with permanent cannulae in the rumen, abomasum and ileum. After post-surgical recovery, the animals were treated orally with a suspension of netobimin zwitterion (400 mg/ml) at 20 mg/kg. Jugular blood and ruminal, abomasal and ileal fluid samples were taken serially over a 96 h period and analysed by HPLC for NTB and its metabolites, including ABZ, ABZ sulphoxide (ABZSO), ABZ sulphone (ABZSO2) and amino-albendazole sulphone (NH2ABZSO2). NTB parent drug was only found in the GI tract and for only 12-18 h post-treatment. ABZSO and ABZSO2 were the main metabolites found in plasma, being present for 30-36 h. These metabolites were exchanged between plasma and different GI fluids and were greatly concentrated in the abomasum. This phenomenon may account for the presence of ABZ, ABZSO and ABZSO2 in the GI tract for 72 h post-treatment despite the fact that ABZ was not detected in plasma and ABZSO and ABZSO2 were detected for only 30-36 h in plasma. The presence of ABZ and ABZSO in the abomasum and intestine for this extended period of time is probably relevant for anthelmintic efficacy against GI parasites. The NH2 ABZSO2 metabolite was detected in plasma, abomasum and ileum and its disposition kinetics were characterized for the first time.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8478999     DOI: 10.1111/j.1365-2885.1993.tb00287.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  9 in total

1.  Enhanced plasma availability of the metabolites of albendazole in fasted adult sheep.

Authors:  A Lifschitz; G Virkel; M Mastromarino; C Lanusse
Journal:  Vet Res Commun       Date:  1997-04       Impact factor: 2.459

2.  Plasma disposition and faecal excretion of netobimin metabolites and enantiospecific disposition of albendazole sulphoxide produced in ewes.

Authors:  C Gokbulut; V Y Cirak; B Senlik
Journal:  Vet Res Commun       Date:  2006-10       Impact factor: 2.459

3.  Albendazole in environment: faecal concentrations in lambs and impact on lower development stages of helminths and seed germination.

Authors:  Lukáš Prchal; Radka Podlipná; Jiří Lamka; Tereza Dědková; Lenka Skálová; Ivan Vokřál; Lenka Lecová; Tomáš Vaněk; Barbora Szotáková
Journal:  Environ Sci Pollut Res Int       Date:  2016-03-21       Impact factor: 4.223

4.  Aspects of the pharmacokinetics of albendazole sulphoxide in sheep.

Authors:  A Goudah
Journal:  Vet Res Commun       Date:  2003-10       Impact factor: 2.459

5.  Exploring flubendazole formulations for use in sheep. Pharmacokinetic evaluation of a cyclodextrin-based solution.

Authors:  Laura Ceballos; Laura Moreno; Juan J Torrado; Carlos Lanusse; Luis Alvarez
Journal:  BMC Vet Res       Date:  2012-05-28       Impact factor: 2.741

6.  Influence of diet on the pattern of gastrointestinal biotransformation of netobimin and albendazole sulphoxide in sheep.

Authors:  G Virkel; A Lifschitz; A Pis; C Lanusse
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Jan-Mar       Impact factor: 2.569

7.  Improvement of Albendazole Bioavailability with Menbutone Administration in Sheep.

Authors:  Raquel Diez; M Jose Diez; Juan J Garcia; Jose M Rodríguez; Cristina Lopez; Nelida Fernandez; Matilde Sierra; Ana M Sahagun
Journal:  Animals (Basel)       Date:  2022-02-14       Impact factor: 2.752

8.  Assessment of Diet-Related Changes on Albendazole Absorption, Systemic Exposure, and Pattern of Urinary Excretion in Treated Human Volunteers.

Authors:  L Ceballos; E Nieves; M Juárez; R Aveldaño; M Travacio; J Martos; R Cimino; J L Walson; A Krolewiecki; C Lanusse; L Alvarez
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

9.  Assessment of serum pharmacokinetics and urinary excretion of albendazole and its metabolites in human volunteers.

Authors:  Laura Ceballos; Alejandro Krolewiecki; Marisa Juárez; Laura Moreno; Fabian Schaer; Luis I Alvarez; Rubén Cimino; Judd Walson; Carlos E Lanusse
Journal:  PLoS Negl Trop Dis       Date:  2018-01-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.